Page 6 - Exact Sciences Corp News Today

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today shared initial clinical validation data...

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that new data presentations...

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that new data presentations...

Companion Diagnostics Market is Expected to Rise at a CAGR of 9% from 2021 to 2028

Exact Sciences Corp., a provider of cancer screening and diagnostics, is planning to lay off approximately 250 workers beginning next week.

/PRNewswire/ -- The breast cancer liquid biopsy testing devices market share growth by the CTCs and circulating nucleic acids segment will be significant...

/PRNewswire/ -- The breast cancer liquid biopsy testing devices market share growth by the CTCs and circulating nucleic acids segment will be significant...

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the company will present new...

ARKG holding Pacific Biosciences (PACB) opened lower on Monday, but is still posting one-month returns topping 48%.

U.S. equities across all sectors are rebounding Thursday following the release of a hotter-than-expected inflation report.